Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes  

Oleh:

Schernthaner, Guntram ; Morton, John M.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Diabetes Care vol. 31 no. Sup 02 (Feb. 2008), page s297-s302.
Topik: Bariatric Surgery

Ketersediaan

Perpustakaan FK Nomor Panggil: D05.K.2008.01 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Even though there are varying degrees of evidence for different surgeries, there is a clear preponderance of evidence for all weight loss surgeries to be vastly superior to traditional weight loss therapies in promoting weight reduction. Obesity is an independent risk factor for cardiovascular disease and contributes strongly to additional risk factors such as hypertension, diabetes, hyperlipidemia, and biochemical inflammatory markers. Cardiac risk among surgically treated morbidly obese patients is greatly diminished by weight loss, comorbidity resolution, and advantageous alteration of biochemical cardiovascular risk factors. Obesity is a worldwide epidemic with serious medical and economic consequences. The only effective and enduring therapy for morbid obesity is weight loss surgery. Weight loss surgery has the unique ability to solve many different health concerns through a single intervention. Certain risks exist for weight loss surgery that can be mitigated by surgical experience and patient selection, education, and lifelong surveillance. Strong evidence supports the well-known benefits of weight loss surgery including weight loss, comorbidity resolution, quality of life improvement, and increased lifespan. Weight loss surgery is a lifesaving intervention in the right patients and in the right hands.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali